ANGELA BOOTH: Open Payments
NPI 1174971600 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 19 payments from 9 companies in 2025. Trend: 2023 $848 · 2024 $938 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Alkermes, Inc. | 3 | $60 |
| Indivior Inc. | 2 | $43 |
| Luye Pharma (USA) Ltd. | 2 | $35 |
| ABBVIE INC. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: COBENFY, VIVITROL, SUBLOCADE, ERZOFRI EXTENDED-RELEASE, AUSTEDO XR, VRAYLAR, UZEDY, HETLIOZ.
Industry payments across NC — which companies pay providers there.
